Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Ovarian Neoplasm Epithelial × Bortezomib × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 52 Neoplasms, Plasma Cell 6 Immunoglobulin Light-chain Amyloidosis 6 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Paraproteinemias 3 Waldenstrom Macroglobulinemia 2 Renal Insufficiency 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Lymphoproliferative Disorders 2 Lymphoma 2 Burkitt Lymphoma 2 beta-Thalassemia 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thalassemia 1 Neoplasm Metastasis 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡